Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358 Meeting Abstract
| Authors: | Topalian, S. L.; Bhatia, S.; Kudchadkar, R. R.; Amin, A.; Sharfman, W. H.; Lebbe, C.; Delord, J. P.; Shinohara, M. M.; Baxi, S. S.; Chung, C. H.; Martens, U. M.; Ferris, R. L.; Stein, J. E.; Soumaoro, I.; Zwirtes, R. F.; Chen, T.; Cao, Z. A.; Taube, J. M.; Nghiem, P. |
| Abstract Title: | Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358 |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 491s |
| Language: | English |
| ACCESSION: | WOS:000442916003282 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9505 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9505 -- Source: Wos |
